159 related articles for article (PubMed ID: 21499937)
1. Use of complementary and alternative medicine among men with prostate cancer in a rural setting.
Butler S; Owen-Smith A; DiIorio C; Goodman M; Liff J; Steenland K
J Community Health; 2011 Dec; 36(6):1004-10. PubMed ID: 21499937
[TBL] [Abstract][Full Text] [Related]
2. Patient-physician communication regarding use of complementary therapies during cancer treatment.
Roberts CS; Baker F; Hann D; Runfola J; Witt C; McDonald J; Livingston ML; Ruiterman J; Ampela R; Kaw OC; Blanchard C
J Psychosoc Oncol; 2005; 23(4):35-60. PubMed ID: 16618687
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.
Jones RA; Taylor AG; Bourguignon C; Steeves R; Fraser G; Lippert M; Theodorescu D; Mathews H; Kilbridge KL
Oncol Nurs Forum; 2007 Mar; 34(2):359-64. PubMed ID: 17573300
[TBL] [Abstract][Full Text] [Related]
4. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
5. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
Boon H; Westlake K; Stewart M; Gray R; Fleshner N; Gavin A; Brown JB; Goel V
Urology; 2003 Nov; 62(5):849-53. PubMed ID: 14624907
[TBL] [Abstract][Full Text] [Related]
6. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
[TBL] [Abstract][Full Text] [Related]
7. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.
Ramsey SD; Zeliadt SB; Blough DK; Fedorenko CR; Fairweather ME; McDermott CL; Penson DF; Van Den Eeden SK; Hamilton AS; Arora NK
Urology; 2012 May; 79(5):1034-41. PubMed ID: 22546381
[TBL] [Abstract][Full Text] [Related]
9. Frequent use of complementary medicine by prostate cancer patients.
Ponholzer A; Struhal G; Madersbacher S
Eur Urol; 2003 Jun; 43(6):604-8. PubMed ID: 12767359
[TBL] [Abstract][Full Text] [Related]
10. Complementary and alternative medicine use by osteoporosis clinic patients.
Chong CA; Diaz-Granados N; Hawker GA; Jamal S; Josse RG; Cheung AM
Osteoporos Int; 2007 Nov; 18(11):1547-56. PubMed ID: 17603742
[TBL] [Abstract][Full Text] [Related]
11. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
[TBL] [Abstract][Full Text] [Related]
12. Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study.
Saxe GA; Madlensky L; Kealey S; Wu DP; Freeman KL; Pierce JP
Integr Cancer Ther; 2008 Sep; 7(3):122-9. PubMed ID: 18956493
[TBL] [Abstract][Full Text] [Related]
13. The use of complementary and alternative medicine after the completion of hospital treatment for colorectal cancer: findings from a questionnaire study in Denmark.
Nissen N; Lunde A; Pedersen CG; Johannessen H
BMC Complement Altern Med; 2014 Oct; 14():388. PubMed ID: 25304122
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine (CAM) use among men with a history of prostate cancer.
Ross LE; Fletcher A; Anderson MC; Meade SA; Powe BD; Howard D
J Cult Divers; 2012; 19(4):143-50. PubMed ID: 23362695
[TBL] [Abstract][Full Text] [Related]
15. Patterns of user disclosure of complementary and alternative medicine (CAM) use.
Shim JM; Schneider J; Curlin FA
Med Care; 2014 Aug; 52(8):704-8. PubMed ID: 25025870
[TBL] [Abstract][Full Text] [Related]
16. Examining the association between patient-centered communication and provider avoidance, CAM use, and CAM-use disclosure.
Faith J; Thorburn S; Tippens KM
Altern Ther Health Med; 2015; 21(2):30-5. PubMed ID: 25830278
[TBL] [Abstract][Full Text] [Related]
17. Information needs and usage of complementary and alternative medicine in members of a German self-help group for gastrointestinal stroma tumours, sarcoma, and renal cancer.
Bauer F; Schmidt T; Eisfeld H; Dubois C; Kastrati K; Hochhaus A; Huebner J
Complement Ther Med; 2018 Dec; 41():105-110. PubMed ID: 30477825
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine: use and disclosure in radiation oncology community practice.
Rausch SM; Winegardner F; Kruk KM; Phatak V; Wahner-Roedler DL; Bauer B; Vincent A
Support Care Cancer; 2011 Apr; 19(4):521-9. PubMed ID: 20336329
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.
Bahall M
BMC Complement Altern Med; 2017 Jun; 17(1):345. PubMed ID: 28666435
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.
Yarney J; Donkor A; Opoku SY; Yarney L; Agyeman-Duah I; Abakah AC; Asampong E
BMC Complement Altern Med; 2013 Jan; 13():16. PubMed ID: 23331546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
